Website Under Maintenance

BPC-157 + TB-500 Blend

BPC-157 + TB-500 Blend
The BPC-157 + TB-500 blend is planned as an upcoming research product in a 10mg/10mg format. It will be offered strictly for laboratory, scientific, and research purposes. The defined blend format allows researchers to clearly identify the composition of the planned research material. It will provide another option within the upcoming research collection for qualified laboratory use. Researchers can monitor the website for availability and product-specific information as the listing becomes active. Request the BPC-157 + TB-500 blend when the product becomes available for research use.

Disclaimer

All products offered by HG Wellness Peptides are strictly intended for laboratory, scientific, and research purposes only. They are NOT for human consumption, clinical use, veterinary application, diagnostic procedures, or direct administration of any kind.

None of the statements on this website have been evaluated or approved by the U.S. Food and Drug Administration (FDA). These products are not medical devices, supplements, or drugs, and are not intended to diagnose, treat, cure, or prevent any disease, condition, or physical ailment.

By purchasing from this website, the buyer acknowledges and agrees that they are at least 21 years of age and are fully qualified, trained, and equipped to handle research chemicals in accordance with applicable laws, health, and safety protocols. HG Wellness Peptides assumes no liability for any direct, indirect, or consequential damages resulting from improper handling, misuse, or unauthorized application of these products.


HG Wellness Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. HG Wellness Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.

Send a Message

Send questions about peptides, orders, or documentation, and our team responds promptly with clear, evidence-based guidance.